Nuclear PARP1‐Targeted Photosensitizer as a Dual‐Mode DNA‐Damaging Agent and Immune Activator for Tumor Ablation
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202301517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Peixia Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Foundation of Shandong Province, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Photodynamic therapy is a promising cancer therapeutic method that can damage DNA via photoinduced reactive oxygen species production. However, tumor cells can initiate DNA repair pathways to resist oxidative damage. In this study, a nuclear‐targeted photosensitizer PARP‐PS with a poly (ADP‐ribose) polymerase 1 (PARP1) inhibitory effect is developed based on the reported PARP1 inhibitor, rucaparib. As a dual‐mode DNA‐damaging agent, PARP‐PS damages DNA upon photoirradiation and enhances oxidative DNA damage by blocking the DNA repair pathway via PARP1 inhibition and degradation. Both in vitro and in vivo investigations demonstrate that PARP‐PS exhibits high antitumor activity with few side effects in breast cancer. In addition, PARP‐PS can act as an immunogenic cell death inducer to activate immune responses characterized by the promotion of cytotoxic T lymphocyte activation and tumor infiltration. Therefore, PARP‐PS is a potential multimodal antitumor agent with synergistic phototherapeutic, chemotherapeutic, and immunotherapeutic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong Provi…
- Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China.
ORCID-Profile: Gang Shan
Förderung
- National Natural Science Foundation of China
- Taishan Scholar Foundation of Shandong Province
- Guangdong Basic and Applied Basic Research Foundation
- Natural Science Foundation of Shandong Province
- Qilu Scholar Program at Shandong University
Zitieren
APA
Li, P., Du, Y., Qiu, J., Li, D., Li, G., & Shan, G. (2023). Nuclear PARP1‐Targeted Photosensitizer as a Dual‐Mode DNA‐Damaging Agent and Immune Activator for Tumor Ablation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301517
Vancouver
Li P, Du Y, Qiu J, Li D, Li G, Shan G. Nuclear PARP1‐Targeted Photosensitizer as a Dual‐Mode DNA‐Damaging Agent and Immune Activator for Tumor Ablation. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301517
BibTeX
@article{Li2023,
author = {Li, Peixia and Du, Yayin and Qiu, Jingru and Li, Donghai and Li, Guiling and Shan, Gang},
title = {Nuclear PARP1‐Targeted Photosensitizer as a Dual‐Mode DNA‐Damaging Agent and Immune Activator for Tumor Ablation},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202301517}
}
EUVIMED